Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Hyperparathyroidism-jaw tumor syndrome.

Kutcher MR, Rigby MH, Bullock M, Trites J, Taylor SM, Hart RD.

Head Neck. 2013 Jun;35(6):E175-7. doi: 10.1002/hed.22918.

PMID:
22302605
2.

Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.

Parfitt J, Harris M, Wright JM, Kalamchi S.

J Oral Maxillofac Surg. 2015 Jan;73(1):194.e1-9. doi: 10.1016/j.joms.2014.09.008. Review.

PMID:
25511968
3.

Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.

Bricaire L, Odou MF, Cardot-Bauters C, Delemer B, North MO, Salenave S, Vezzosi D, Kuhn JM, Murat A, Caron P, Sadoul JL, Silve C, Chanson P, Barlier A, Clauser E, Porchet N, Groussin L; GTE Group..

J Clin Endocrinol Metab. 2013 Feb;98(2):E403-8. doi: 10.1210/jc.2012-2789. Erratum in: J Clin Endocrinol Metab. 2013 Apr;98(4):1766.

PMID:
23293331
4.

[Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma].

Raue F, Haag Ch, Frank-Raue K.

Dtsch Med Wochenschr. 2007 Jul 29;132(27):1459-62. German.

PMID:
17583828
5.

[Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].

Frank-Raue K, Leidig-Bruckner G, Lorenz A, Rondot S, Haag C, Schulze E, Büchler M, Raue F.

Dtsch Med Wochenschr. 2011 Sep;136(38):1889-94. doi: 10.1055/s-0031-1286358. German.

PMID:
21915802
6.

Recurrent hyperparathyroidism and a novel nonsense mutation in a patient with hyperparathyriodism-jaw tumor syndrome.

Abdulla AG, O'Leary EM, Isorena JP, Diaz MF, Yeh MW.

Endocr Pract. 2013 Nov-Dec;19(6):e134-7. doi: 10.4158/EP13187.CR.

PMID:
23757631
7.

Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred.

Iacobone M, Masi G, Barzon L, Porzionato A, Macchi V, Ciarleglio FA, Palù G, De Caro R, Viel G, Favia G.

Langenbecks Arch Surg. 2009 Sep;394(5):817-25. doi: 10.1007/s00423-009-0511-y.

PMID:
19529956
8.

Hyperparathyroidism-jaw tumor syndrome: Results of operative management.

Mehta A, Patel D, Rosenberg A, Boufraqech M, Ellis RJ, Nilubol N, Quezado MM, Marx SJ, Simonds WF, Kebebew E.

Surgery. 2014 Dec;156(6):1315-24; discussion 1324-5. doi: 10.1016/j.surg.2014.08.004.

9.

Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.

Mizusawa N, Uchino S, Iwata T, Tsuyuguchi M, Suzuki Y, Mizukoshi T, Yamashita Y, Sakurai A, Suzuki S, Beniko M, Tahara H, Fujisawa M, Kamata N, Fujisawa K, Yashiro T, Nagao D, Golam HM, Sano T, Noguchi S, Yoshimoto K.

Clin Endocrinol (Oxf). 2006 Jul;65(1):9-16.

PMID:
16817812
10.

CDC73-Related Disorders.

Jackson MA, Rich TA, Hu MI, Perrier ND, Waguespack SG.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2008 Dec 31 [updated 2015 Jan 15].

11.

Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family.

Cascón A, Huarte-Mendicoa CV, Javier Leandro-García L, Letón R, Suela J, Santana A, Costa MB, Comino-Méndez I, Landa I, Sánchez L, Rodríguez-Antona C, Cigudosa JC, Robledo M.

Genes Chromosomes Cancer. 2011 Nov;50(11):922-9. doi: 10.1002/gcc.20911.

PMID:
21837707
12.

Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.

Shibata Y, Yamazaki M, Takei M, Uchino S, Sakurai A, Komatsu M.

Endocr J. 2015;62(7):627-32. doi: 10.1507/endocrj.EJ15-0057.

13.

Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.

Lee JY, Kim SY, Mo EY, Kim ES, Han JH, Maeng LS, Lee AH, Eun JW, Nam SW, Moon SD.

Int J Oncol. 2014 Aug;45(2):641-50. doi: 10.3892/ijo.2014.2477.

PMID:
24889687
14.

Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.

Kelly TG, Shattuck TM, Reyes-Mugica M, Stewart AF, Simonds WF, Udelsman R, Arnold A, Carpenter TO.

J Bone Miner Res. 2006 Oct;21(10):1666-71.

15.

[Prophylactic parathyroidectomy for familial parathyroid carcinoma].

Gimm O, Lorenz K, Nguyen Thanh P, Schneyer U, Bloching M, Howell VM, Marsh DJ, Teh BT, Krause U, Dralle H.

Chirurg. 2006 Jan;77(1):15-24. German.

PMID:
16418876
16.

Hyperparathyroidism-jaw tumor syndrome: a case report.

Rekik N, Ben Naceur B, Mnif M, Mnif F, Mnif H, Boudawara T, Abid M.

Ann Endocrinol (Paris). 2010 Mar;71(2):121-6. doi: 10.1016/j.ando.2009.09.004.

PMID:
19942209
17.

A case of hyperparathyroidism-jaw tumour syndrome found in the treatment of an ossifying fibroma in the maxillary bone.

Yamashita Y, Akiyama T, Mizusawa N, Yoshimoto K, Goto M.

Int J Oral Maxillofac Surg. 2007 Apr;36(4):365-9.

PMID:
17052894
18.

Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.

Kong J, Wang O, Nie M, Shi J, Hu Y, Jiang Y, Li M, Xia W, Meng X, Xing X.

Clin Endocrinol (Oxf). 2014 Aug;81(2):222-30. doi: 10.1111/cen.12461.

PMID:
24716902
19.
20.

Primary hyperparathyroidism: a current perspective.

DeLellis RA, Mazzaglia P, Mangray S.

Arch Pathol Lab Med. 2008 Aug;132(8):1251-62. doi: 10.1043/1543-2165(2008)132[1251:PHACP]2.0.CO;2. Review.

PMID:
18684024

Supplemental Content

Support Center